Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Localised Impetigo Common organisms: Staphylococcus aureus Streptococcus pyogenes |
Cloxacillin 500-1000mg PO q6h for 5-7 days OR Cephalexin 250-500mg PO q6h for 5-7 days OR Cefadroxil 500mg PO q12h for 7 days |
Topical 2% Fusidic acid q8-12h for 5 days (Outpatient use only) |
|
Generalised Impetigo/ Ecthyma |
Cephalexin 250-500mg PO q6h OR Cefadroxil 500mg PO q12h |
Amoxicillin-clavulanate 625mg PO q8h |
Duration : 5-7 days. |
|
Penicillin allergy: Erythromycin ethylsuccinate 800mg PO q12h |
Other alternative/ in case of CA- MRSA: Clindamycin 600mg PO q8h OR Trimethoprim-sulfamethoxazole 160/800mg PO q12h |
|
Ecthyma gangrenosum Pseudomonas spp. |
Ciprofloxacin 500mg PO q12h OR Piperacillin-tazobactam 4.5gm IV q6-8h |
Ceftazidime 2gm IV q8h OR Cefepime 2gm IV q8h |
Consider adding aminoglycoside in selected cases such as in immunocompromised, neutropenic and septic shock patients. |
SKIN AND SOFT TISSUE INFECTIONS
exp date isn't null, but text field is
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Furuncles |
Cloxacillin 500mg PO q6h for 5-7 days |
Amoxicillin-clavulanate 625mg PO q8h for 5-6 days |
|
Carbuncles Common organism: Staphylococcus aureus |
Cloxacillin 1-2gm IV q6h |
Cefazolin 1gm IV q8h OR Amoxicillin-clavulanate 1.2gm IV q8h |
Surgical drainage is the mainstay of treatment. Duration : 7-10 days. |
Erysipelas Common organism: Streptococcus pyogenes |
Phenoxymethylpenicillin 500mg PO q6h OR Amoxicillin 500mg PO q8h |
Cephalexin 500mg PO q6h |
Duration : 7-10 days. |
If severe: Benzylpenicillin 2-4MU IV q4-6h |
If severe: Cefazolin 1gm IV q8h OR Cefuroxime 750mg IV q8h |
||
MRSA: *Vancomycin 15-20mg/kg q8-12h; not to exceed 2gm/dose |
|
|
|
Diabetic Foot Infections |
Refer to section Surgical Infection – Diabetic Foot Infections |
||
Gas Gangrene / Myonecrosis / Necrotizing Fasciitis |
Refer to section Surgical Infection – Bone and Joint Infections |
||
Yaws Treponema pertenue |
Benzathine penicillin G 1.2MU IM single dose |
Doxycycline 100mg PO q12h for 15 days OR Azithromycin 30mg/kg (max 2gm) single dose Penicillin allergy: Tetracycline 500mg PO q6h for 15 days OR Erythromycin ethylsuccinate 800mg PO q12h for 15 days |
|
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Mild: Common organisms: Staphylococcus aureus Streptococcus pyogenes |
Cephalexin 500mg PO q6h |
Amoxicillin-clavulanate 625mg PO q8h OR Cefuroxime 250-500mg PO q12h |
Duration: 5-10 days Change to oral once condition improves. Gram negative coverage may be necessary in the following circumstances:
Clinical Condition:
|
Moderate: Common organisms: Staphylococcus aureus Streptococcus pyogenes |
Cloxacillin 1-2gm IV q6h |
Cefazolin 1-2gm IV q8h |
|
Severe: Common organisms: Staphylococcus aureus Streptococcus pyogenes |
Ampicillin-sulbactam 3gm IV q6-8h PLUS* Clindamycin 600mg IV q6h (Deescalate once cultures are available/Necrotizing fasciitis ruled out) |
Piperacillin-tazobactam 4.5gm IV q6-8h PLUS* Clindamycin 600mg IV q6h (Deescalate once cultures are available/Necrotizing fasciitis ruled out) |
|
Consider alternative organisms in the following circumstances: |
*** Consider adding 3rd Generation Cephalosporin in severe infection. |
||
Dog/cat bite: Common organisms: Pasteurella multocida Capnocytophaga canimorsus |
Amoxicillin-clavulanate 625mg PO q8h |
|
|
Cat scratch disease Bartonella henselae |
Azithromycin 500mg PO on Day 1, then 250mg PO q24h for 4 days |
|
|
Human bite: Common organisms: Eikenella corrodens anaerobes Staphylococcus aureus |
Amoxicillin-clavulanate 625mg PO q8h |
|
|
Salt water exposure: Common organism: Vibrio sp. |
Doxycycline 200mg stat then 100mg PO q12h PLUS ***Ceftriaxone 2gm IV q24h |
|
|
Fresh or brackish water exposure: Common organisms: Aeromonas spp., Plesiomonas spp. |
Ciprofloxacin 400mg IV q12h OR Ciprofloxacin 750mg PO q12h |
|
|
Neutropenic patients: Common organisms: Pseudomonas aeruginosa, other Gram-negative bacteria |
Piperacillin-tazobactam 4.5gm IV q6-8h |
Ceftazidime 2gm IV q8h OR Cefepime 2gm IV q8h |
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
MRSA |
Vancomycin 15-20mg/kg IV q8-12h In severe infections: To load with Vancomycin 25-30mg/kg IV, followed by 15-20mg/kg (actual body weight) IV q8-12h; not exceeding 2gm /dose |
Linezolid 600mg IV/PO q12h |
****Consider CA-MRSA if: Outbreaks of known CA-MRSA If non-resolving cellulitis. |
**** If CA-MRSA suspected |
Clindamycin 300-450mg IV/PO q8h OR Doxycycline 100mg PO q12h OR Trimethoprim-sulfamethoxazole 160/800mg PO q12h |
|
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Common organisms: Staphylococcus aureus, Coagulase negative Staphylococcus sp., Gram negative rods |
Early stage phlebitis: Remove the intravenous cannula |
|
Peripheral intravenous catheters with associated pain, induration, erythema, or exudate should be removed. |
Medium and advanced stage phlebitis or thrombophlebitis: Remove the intravenous cannula and take blood culture Can consider empirical treatment if persistent fever: Cephalexin 500mg PO q6h OR Cloxacillin 1-2gm IV q6h |
Infection/Condition and Likely Organism |
Suggested Treatment |
|
Preferred |
Alternative |
|
Bed Sore/Pressure Sore/Decubitus Ulcer |
Local treatment is preferred. If there is surrounding cellulitis/signs of bacteremia/ fasciitis/ surrounding intramuscular abscess/ osteomyelitic changes (OM) changes: Ampicillin-sulbactam 3gm IV q6-8h |
|
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Refer to National Tuberculosis Management Guidelines 2019 |
|||
Hansen’s Disease (Leprosy) in HIV infected |
Same as in non HIV infected patients |
||
Non-Tuberculous Mycobacterial Infections |
|||
Mycobacterium marinum |
Clarithromycin 500mg PO q12h PLUS Minocycline/Doxycycline 100mg PO q12h Duration: At least 2 months of treatment until clearance |
Rifampicin 600mg PO q24h PLUS Ethambutol 15mg/kg PO q24h for 4-6 months, and continue for at least 1 month after lesions have been cleared OR Monotherapy Doxycycline 100mg PO q12h for 1-2 months after lesion clearance (3-4 months) |
Often resistant to Isoniazid |
Mycobacterium kansasii |
Isoniazid 300mg PO q24h PLUS Rifampicin 600mg PO q24h PLUS Ethambutol 15mg/kg PO q24h for 18 months |
|
|
Mycobacterium ulcerans (Buruli ulcer) |
Rifampicin 10mg/kg PO q24h PLUS Streptomycin 15mg/kg IM q24h for 8 weeks |
Rifampicin 10mg/kg PO q24h PLUS Streptomycin 15mg/kg IM q24h for 4 weeks Followed by: Rifampicin 10mg/kg PO q24h PLUS Clarithromycin 7.5mg/kg PO q12h |
Wide surgical excision and debridement are important. Duration: For 4-6 months, and continue for at least 1 month after lesions have been cleared. |
Mycobacterium fortuitum |
Combination therapy (2 of the following): Clarithromycin 500mg PO q12h OR Doxycycline/Minocycline 100mg PO q12h OR Ciprofloxacin 500-750mg PO q12h PLUS* *Amikacin 15mg/kg IV q24h |
|
*Amikacin: Started for severe infection until clinical improvement (together with 2 oral agents), then continue with just 2 oral agents. |
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Tinea capitis Trichophyton Microsporum |
Griseofulvin 500mg PO q12h for 6 to 12 weeks or longer till fungal cultures are negative OR Terbinafine 250mg PO q24h for 6-8 weeks PLUS 2.5% Selenium sulphide shampoo OR 2% Ketoconazole shampoo, 2-3 times per week for 2 weeks |
Itraconazole 200mg PO q24h Duration is based on mycological agent: Trichophyton sp : 2-4 weeks Microsporum sp : 8-12 weeks |
Other recommendations:
|
Tinea barbae |
Same as treatment of Tinea capitis |
||
Tinea corporis/ Tinea cruris/Tinea faciei Trichophyton Mircosporum Epidermophyton |
Mild infection: Topical imidazoles or allylamines cream/lotion: e.g.: Terbinafine/Butenafine/ Sertaconazole/ Luliconazole Duration: till clinical clearance with additional 2 weeks |
|
Recommendations:
|
Extensive infections or Tinea incognito (Steroid modified) Above PLUS Terbinafine 250mg PO q24h for 2 weeks OR Itraconazole 200mg PO q24h for 2 weeks OR Griseofulvin 500mg PO q12h or q24h for 4-6 weeks |
|
|
|
Tinea manuum/ Tinea pedis Trichophyton, Microsporum, Epidermophyton |
Terbinafine 250mg PO q24h for 2-4 weeks OR Itraconazole 200mg PO q24h for 2-4 weeks OR Griseofulvin 500mg PO q12h or q24h for 6-12 weeks Along with TOPICAL Antifungals |
Fluconazole 150mg/week PO for 4 weeks |
Recommendations: Topical keratolytic agents can be used in conjunction with antifungals for hyperkeratotic type of tinea pedis/manuum. KMnO4 in 1:10,000 dilution wet dressings, applied for 20 min 2-3 times/day, may be helpful if vesiculation or maceration is present. Systemic antifungals can be prescribed as first line treatment in severe moccasin-type tinea pedis or severe recurrent tinea with blisters. |
Tinea unguim |
Amorolfine 5% Nail
OR Terbinafine 250mg PO |
Griseofulvin 500mg PO |
Amorolfine 5% Lacquer is
|
Tinea versicolor Malassezia furfur Pityrosporum orbiculare
|
First line: Topical
|
|
Recommendations: |
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Candida albicans |
Mild cutaneous candidiasis: Topical Imidazole q12h till clear e.g., Miconazole 2% cream, Clotrimazole 1% cream, Sertaconazole 1% cream |
|
Treatment of sexual partner is advisable in case of recurrent infection.
*Itraconazole: Absorption depends on gut acidity. Take capsule with food and acidic beverage (e.g.: Cola drinks). Avoid PPIs and H2 blockers. |
Extensive cutaneous candidiasis: *Itraconazole 200mg PO q24h for 1 week Vulvovaginitis/ Balanoposthitis: Fluconazole 150mg stat dose |
Fluconazole 100mg PO q24h for 1 week (in severe and immunocompromised patients) |
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Subcutaneous Fungal infections Lymphocutaneous and Cutaneous Sporotrichosis |
*Itraconazole 200mg PO q12h until all lesions have resolved (usually for a total of 2-6 months) |
For patients not able to tolerate Itraconazole: Terbinafine 250mg PO q12h OR Fluconazole 400-800mg q24h |
In some immunocompromised condition such as AIDS, longer treatment may be necessary. Refer to Opportunistic Infections in HIV Patients. *Itraconazole: Absorption depends on gut acidity. Take capsule with food and acidic beverage (e.g.: Cola drinks). Avoid PPIs and H2 blockers. **Avoid azole in pregnancy. |
Systemic sporotrichosis (pulmonary, osteoarticular, meningeal, or disseminated sporotrichosis) |
Amphotericin B deoxycholate 0.7-1mg/kg q24h for 2 weeks Followed by, *Itraconazole 200mg PO q12-24h for 12 months |
|
|
Sporotrichosis in Pregnancy** |
Terbinafine 250mg PO q24h |
Amphotericin B deoxycholate 0.7-1mg/kg q24h |
|
Cutaneous fungal infection in immunocompromised patients |
Refer to treatment of disseminated fungal infection in immunocompromised/HIV patients Opportunistic Infections in HIV patients |
Skin biopsy for histopathologic examination (HPE) and culture are advised before commencing treatment. |
|
Aspergillus spp., Scedosporium Apiospermum, and Fusarium sp Infection |
Voriconazole 6mg/kg IV q12h for 2 doses, followed by 4mg/kg IV q12h |
Amphotericin B (deoxycholate) 0.7-1mg/kg q24h OR Amphotericin B (lipid formulation) 3-5mg/kg q24h |
|
Cryptococcal infections Mild Life threatening |
Fluconazole 100-400mg PO q24h Refer to Treatment of disseminated fungal infection in immunocompromised/HIV patients Opportunistic Infections in HIV patients |
|
|
Penicilliosis and life threatening acute severe disseminated Histoplasmosis |
Refer to Treatment of disseminated fungal infection in immune compromised/HIV patients Opportunistic Infections in HIV patients |
Infection/Condition and Likely Organism |
Suggested Treatment |
Comments |
|
Preferred |
Alternative |
||
Herpes Simplex Infections |
Mild infection: Acyclovir 400mg PO q8h for 5 days |
Valacyclovir 1gm PO q12h |
|
Severe life threatening: Acyclovir 5-10mg/kg IV q8h for 5 days or until able to take orally, then change to oral |
|
|
|
Genitalia: Refer to National STI guidelines |
|
|
|
Chickenpox (Varicella zoster) |
Immunocompetent Acyclovir 800mg PO 5 times daily for 7 days |
Valacyclovir 1gm PO q8h |
Advisable to start treatment early within 48 hours. |
Immunocompromised Acyclovir 10mg/kg IV q8h for 7 days (change to oral once there is an improvement) |
|
||
Herpes zoster |
Please refer to varicella zoster treatment above |
|
Topical antiviral treatment is not recommended for Herpes Zoster. Systemic antiviral treatment is recommended for all immunocompromised patient or for immunocompetent patients with following criteria:
Advisable to start treatment early within 48-72 hours. |
Infection/Condition and Likely Organism |
Suggested Treatment |
|
Preferred |
Alternative |
|
Scabies Sarcoptes scabiei |
Permethrin 5% lotion/ cream apply and leave overnight, clean next day, family treatment, wash clothes PLUS Antihistamines Repeat application after 1 week |
Tab. *Ivermectin 6mg 2 tabs stat, repeat after 1 week *Not recommended for children <12 years or <15kg |
|
In pregnancy/ Immunocompromised: Permethrin 5% lotion/ cream apply and leave for 8 hours Repeat application after 1 week |
|
Head Lice Pediculus humanus capitis |
Permethrin 1% lotion apply to scalp for 10 min and wash off OR Malathion 1% shampoo Repeat application after 1 week |
|
Body Lice/Pubic Lice Pediculus humanus |
Malathion lotion 0.5% for 8-12 hours and wash off OR Permethrin 1% cream apply to affected area for 10 min and wash off |
|